The clinical and pathological data of 216 Stage I to III patients with TNBC who were. . The overall and disease-free survival rates (DFS) over the 5-year study .
Triple–negative breast cancer (TNBC) is characterized by the lack of. those with a BRCA1 gene mutation, and it carries a poor prognosis.. that TNBC had a local control rate and overall survival rate of 89.6% and 78.5%,. . 2015;33(1):13-21. doi: 10.1200/JCO.2014.57.0572. von Minckwitz G, Schneeweiss A, Loibl S, et al.
Women with triple negative breast cancer are no more likely to have relapsed or. estimates of rates of survival for triple negative patients depending on multiple factors.. One 2015 study reported that a delay of more than 90 days in starting .
of triple negative breast cancers fall in to the basal-like sub-. Female Breast Cancer Incidence and Mortality Rates* by Race/Ethnicity and State, 2008-2012.
Higher rates of triple negative/basal-like tumors may explain, to some degree, the poor prognosis of breast cancers diagnosed in younger Black/non-Hispanic .